ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Division Spotlight
Nuclear Nonproliferation Policy
The mission of the Nuclear Nonproliferation Policy Division (NNPD) is to promote the peaceful use of nuclear technology while simultaneously preventing the diversion and misuse of nuclear material and technology through appropriate safeguards and security, and promotion of nuclear nonproliferation policies. To achieve this mission, the objectives of the NNPD are to: Promote policy that discourages the proliferation of nuclear technology and material to inappropriate entities. Provide information to ANS members, the technical community at large, opinion leaders, and decision makers to improve their understanding of nuclear nonproliferation issues. Become a recognized technical resource on nuclear nonproliferation, safeguards, and security issues. Serve as the integration and coordination body for nuclear nonproliferation activities for the ANS. Work cooperatively with other ANS divisions to achieve these objective nonproliferation policies.
Meeting Spotlight
Nuclear Energy Conference & Expo (NECX)
September 8–11, 2025
Atlanta, GA|Atlanta Marriott Marquis
Standards Program
The Standards Committee is responsible for the development and maintenance of voluntary consensus standards that address the design, analysis, and operation of components, systems, and facilities related to the application of nuclear science and technology. Find out What’s New, check out the Standards Store, or Get Involved today!
Latest Magazine Issues
Jun 2025
Jan 2025
Latest Journal Issues
Nuclear Science and Engineering
August 2025
Nuclear Technology
July 2025
Fusion Science and Technology
Latest News
DOE extends Centrus’s HALEU production contract by one year
Centrus Energy has announced that it has secured a contract extension from the Department of Energy to continue—for one year—its ongoing high-assay low-enriched uranium (HALEU) production at the American Centrifuge Plant in Piketon, Ohio, at an annual rate of 900 kilograms of HALEU UF6. According to Centrus, the extension is valued at about $110 million through June 30, 2026.
Dr. Larry R. Foulke has been a member of the American Nuclear Society since 1967. He is currently an adjunct full professor who has an earned doctorate in nuclear engineering, PE registration (nuclear) in the State of Pennsylvania, and extensive experience in nuclear science and technology from a 40-year career in the nuclear industry.
Dr. Foulke has held many ANS leadership positions including Chair of the Accreditation Policies and Procedures Committee, Public Policy Committee and PE Exam Committee.
In 2006, Foulke retired from his career assignments at the U.S. Army Nuclear Power Field Office, Westinghouse Nuclear, and the Bettis Atomic Power Laboratory. He served in the U.S. Army Corps of Engineers coming out as Captain in 1968. Dr. Foulke has been active in the Accreditation Board for Engineering and Technology (ABET) serving as Chair of the Technology Accreditation Commission in 1992-93, and member of the Engineering Accreditation Commission. He was made a Fellow of ABET in 1995.
Serving as the founder and director of the Nuclear Engineering Certificate Program at the University of Pittsburgh from 2006 to 2012, he created a series of courses in nuclear engineering for both undergraduate and graduate students. One course in particular entitled, “A Look at Nuclear Science and Technology” reached over 30,000 students in 179 countries in 2013 and 2014.
Dr. Foulke received his BS and MS in Nuclear Engineering from Kansas State University and his PhD in Nuclear Engineering from MIT. He served as a Fulbright Fellow at the University of Oslo/Institute for Atomenergi in Norway in 1961-62. Recognized in 2003 by Kansas State University, he was as a Distinguished Member of the College of Engineering Hall of Fame. Dr. Foulke currently resides in Pleasant Hills, PA.
Read Nuclear News from July 2003 for more on Dr. Foulke.
